About CPF
Company Profiles
Awards
Global Collaboration
Media Center
Subsidiary
Products & Services
API and intermediates
Dosage
Services
R&D
News
Company News
Industry News
Contact Us
中
About CPF
Products & Services
R&D
News
Contact Us
API and intermediates
Dosage
Services
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No.
API
CAS No.
Indication
21
Ledipasvir Actone /PVP
1256388-51-8
HCV
22
Lenalidomide
191732-72-6
Oncology drug
23
Niraparib
1038915-60-4
Ovarian/Fallopian,tube/primary peritoneal cancer
24
Obeticholic Acid
459789-99-2
Biliary cholangitis
25
Pitavastatin Calcium
147526-32-7
Hypercholesterolemia
26
Pregabalin
148553-50-8
Epilepsy/Neuralgia
27
Relugolix
737789-87-6
Antineoplastic
28
Ribociclib
1374639-75-4
HR-positive, HER2-negative Andvance ormetastaticbreast Cancers
29
Rimegepant
1289023-67-1
Migraine headache
30
Rivaroxaban
366789-02-8
Anticoagulant
31
Rosuvastatin Calcium
147098-20-2
Hypercholesterolemia
32
Ruxolitinib
941678-49-5
Myelofibrosis
33
Sacubitril Hemicalcium
1369773-39-6
Heart failure
34
Sofosbuvir
1190307-88-0
HCV
35
Sugammadex Sodium
343306-79-6
Neuromuscular blockade
36
Thalidomide
50-35-1 & 731-40-8
Oncology drug
37
Ticagrelor
274693-27-5
Anticoagulant
38
Tofacitinib Citrate
540737-29-9
Rheumatoid arthritis
39
Velpatasvir(PVP)
1377049-84-7
HCV
40
Venetoclax
1257044-40-8
CLL
1
2
3
Leave Your Message
SAND OUT